Literature DB >> 6800961

Detection of antibodies to streptococcal mucopeptide in patients with rheumatic disorders and normal controls.

R M Pope, J E Rutstein, D C Straus.   

Abstract

Bacterial mucopeptide is an integral part of bacterial cell walls and is therefore ubiquitous in our environment. An enhanced degree of humoral immunity has ben detected not only in patients with acute rheumatic fever (ARF), with a known recent response to streptococci, but also in patients with adult and juvenile rheumatoid arthritis (RA and JRA). Our studies confirmed this association with ARF and JRA using a precipitin system as well as a radioimmunoassay to detect IgG anti-mucopeptide antibodies. In those with adult RA, either IgM or IgA rheumatoid factors or IgM or IgA antibodies specific for mucopeptide were responsible for the increased incidence of precipitins to mucopeptide in the RA patients detected in this and other studies. No differences in the specificities of the anti-mucopeptide antibodies were noted between the various patient populations as there were no lines of partial identity or nonidentity when examined by Ouchterlony double diffusion analyses. Additionally, no differences of anti-mucopeptide antibody were observed when the sera from these same patient populations were examined employing inhibition studies utilizing N-acetylglucosamine and rhamnose.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800961     DOI: 10.1159/000233029

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  2 in total

1.  Antibodies to peptidoglycan in patients with spondylarthritis: a clue to disease aetiology?

Authors:  H Park; H R Schumacher; A R Zeiger; J T Rosenbaum
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

Review 2.  Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.

Authors:  J H Schwab
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.